Quintiles Information Library Custom Feed

Quintiles Wins Best CRO In Vaccine Excellence Awards 2012

Thu, 12 Apr 2012 13:30:00 -0400

April 12, 2012 – Quintiles, the world’s leading global biopharmaceutical services company, announced that it has been named Best Clinical Research Organization (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012.

Cancer Treatments and the Search for Value

Mon, 02 Apr 2012 15:12:25 -0400

Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer

World Vaccine Congress

Mon, 12 Mar 2012 17:01:42 -0400

Quintiles is a Gold Sponsor and Ellen Vigdorth is speaking

Accelerating Success in Oncology

Fri, 09 Mar 2012 09:26:52 -0400

New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity Download the PDF

DIA China

Fri, 03 Feb 2012 11:56:04 -0400

Quintiles will have a presence

Quintiles Forms New Biomarker Research and Development Company

Wed, 18 Jan 2012 06:00:00 -0400

January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.

DIA US 2012

Thu, 12 Jan 2012 11:06:15 -0400

Quintiles will have an exhibit

Intarcia and Quintiles Finalize Innovative Alliance

Tue, 13 Dec 2011 07:43:17 -0400

December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

Quintiles Launches China CRO, Kun Tuo

Tue, 13 Dec 2011 07:01:52 -0400

December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

Quintiles Names New Global Head of Clinical & Data Operations

Thu, 06 Oct 2011 06:00:00 -0400

October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

Energizing Enrollment

Tue, 04 Oct 2011 14:22:38 -0400

The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. Download the PDF

Partnering is Key to Maximizing Rewards in Emerging Markets

Tue, 27 Sep 2011 06:00:00 -0400

September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

A Focus on CNS

Fri, 01 Jul 2011 15:20:45 -0400

Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. Download the PDF

Australia and New Zealand Phase II/III Fact Sheet

Fri, 24 Jun 2011 15:53:36 -0400

Australia and New Zealand fact sheet around Phase II/III trials. Same language. Same technology. Same quality standards. Download the PDF

Malaria Prevention in Sub-Saharan Africa

Fri, 24 Jun 2011 14:30:30 -0400

This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands Download the PDF

The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

Thu, 23 Jun 2011 14:33:45 -0400

In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. Download the PDF

KoNECT & Quintiles Partner to Advance Clinical Research

Mon, 30 May 2011 01:00:00 -0400

May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

Quintiles Reaches New Milestone in Social Health

Mon, 28 Mar 2011 14:07:47 -0400

March 28, 2011 – Quintiles announced that its online social community at www.MediGuard.org has reached 2.5 million members in just three years.

Podcast: MediGuard's Membership Milestone

Fri, 25 Mar 2011 16:10:43 -0400

Hugo Stephenson, President of MediGuard, dicusses the 2.5 million member milestone.

Biomarkers in Alzheimers Disease

Thu, 17 Mar 2011 09:06:55 -0400

The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. Download the PDF

Constant Vigilance

Wed, 16 Mar 2011 13:31:46 -0400

Centralized planning played a key role in improving productivity during site visits and close monitoring ensured the high standards Quintiles put in place were met. Download the PDF

Recruiting Trust

Wed, 16 Mar 2011 13:21:22 -0400

Quintiles enrolls 2 cancer trials, 2 times faster than projected Download the PDF

Clinical – Smarter Trials, Accelerated Outcomes

Wed, 16 Feb 2011 09:25:24 -0400

Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. Download the PDF

Population PK/PD - Modeling and Simulation Optimization Tools

Fri, 11 Feb 2011 14:05:21 -0400

Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. Download the PDF

Timely Results - Flu Vaccine

Wed, 02 Feb 2011 11:32:53 -0400

Streamlined processes for study startup, coupled with experience in vaccine trials and solid relationships with study sites and investigators, helped this Quintiles team meet the challenge of starting an influenza vaccine trial late in the influenza season.

Acute Coronary Syndrome - Tailored Solutions

Tue, 01 Feb 2011 13:22:42 -0400

Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO. Download the PDF

Exclusive Report From Scientific American

Tue, 09 Nov 2010 08:55:28 -0400

In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

Healthcare's Future Tools

Mon, 08 Nov 2010 11:22:22 -0400

Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report.

Oncology Drug Development and Value-Based Medicine

Fri, 05 Nov 2010 14:57:57 -0400

This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. Download the PDF

Pharmacobiomics and Infectious Disease: Progress and Opportunities

Tue, 02 Nov 2010 08:35:43 -0400

Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. Download the PDF

From Biomarkers to Diagnostics - The Road to Success

Mon, 18 Oct 2010 10:43:12 -0400

In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. Download the PDF

Advancing Clinical Research in Alzheimer's Disease

Mon, 18 Oct 2010 10:13:05 -0400

This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. Download the PDF

QUINTILES TO BE KEY PARTICIPANT AT SOCIETY FOR CLINICAL DATA MANAGEMENT ANNUAL CONFERENCE

Tue, 12 Oct 2010 08:42:03 -0400

October 12, 2010 - Quintiles’ Paula Brown Stafford, President, Clinical Development will open the conference with a keynote speech on the evolution from data management to information management.

QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL

Wed, 06 Oct 2010 12:00:00 -0400

October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.

Management of Tissue Specimens for Oncology Drug Development in China

Fri, 01 Oct 2010 11:07:10 -0400

Download Patty James of Quintiles recent presentation Management of Tissue Specimens for Oncology Drug Development in China from the Clinical Development of Cancer Drugs in China

Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries

Fri, 01 Oct 2010 10:58:33 -0400

Download Christopher Ung of Quintiles recent presentation, Outsourcing Oncology Molecular Biomarkers - Considerations for Emerging Countries from the Clinical Development of Cancer Drugs in China Download the PDF

New Global Trends in Novel Oncology Drug Development

Fri, 01 Oct 2010 10:37:43 -0400

Download Harish Dave, MD, MBA of Quintiles recent presentation New Global Trends in Novel Oncology Drug Development from the Clinical Development of Cancer Drugs

Personalized Anti-Cancer Therapy Development in China

Fri, 01 Oct 2010 10:17:16 -0400

Download the slides from Michael Shi, M.D. of Novartis recent presentation, Personalized Anti-Cancer Therapy Development in China from the Clinical Development of Cancer Drugs in China

The Evolving Role of Neuroimaging in Future AD Clinical Trials

Tue, 21 Sep 2010 15:01:20 -0400

Download the slides from Philip Scheltens, MD VU Medical Center, Amsterdam recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials

Central and Eastern Europe and the Middle East Phase II/III Fact Sheet

Wed, 15 Sep 2010 15:58:07 -0400

Central and Eastern Europe and the Middle East fact sheet on Phase II/III trials. As the market leader with more than 10 years’ experience, Quintiles has established clinical trial standards in the region. Download the PDF

Southeast Asia Phase II/III Fact Sheet

Wed, 15 Sep 2010 15:51:26 -0400

This fact sheet on phase II/III clinical development in Southeast Asia demonstrates our unmatched experience and expertise ensure high-quality, on-time project delivery. Download the PDF

India Phase II/III Fact Sheet

Wed, 15 Sep 2010 15:47:21 -0400

Learn about the unbeatable combination of Quintiles’ local experience, quick patient access, high-quality results and lower costs for Phase II/III Clinical Services in India. Download the PDF

Latin America Phase II/III Fact Sheet

Wed, 15 Sep 2010 15:43:44 -0400

In this Phase II/III Clinical Services fact sheet, learn how we increase the speed of your studies with our highly skilled investigators and Latin America’s diverse patient population and climate. Download the PDF

Advancing Prevention in Korea

Tue, 14 Sep 2010 17:25:30 -0400

The original recruitment target and timeline were met with more than 1,100 patients screened to yield 420 randomized patients.

Managing Trauma

Tue, 14 Sep 2010 16:58:57 -0400

Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only. Download the PDF

The New Health Clinical Brochure

Tue, 31 Aug 2010 14:34:37 -0400

Japanese version available for download. Download the PDF

Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

Thu, 19 Aug 2010 10:13:23 -0400

Richard Gaynor, MD of Eli Lilly presents Biomarkers as an Approach to Improving Productivity in Oncology Drug Development

Behavior as an Outcome in Disease Modifying AD Trials

Fri, 06 Aug 2010 16:03:23 -0400

Watch the video of Jeffrey Cummings, M.D. of Cleveland Clinic recent presentation, Behaviors as an Outcome in Disease Modifying AD Trials from the Quintiles Symposium at ICAD 2010

QUINTILES ANNOUNCES CLINICAL RESEARCH PARTNERSHIP WITH THE UNIVERSITY MALAYA MEDICAL CENTRE

Mon, 05 Jul 2010 06:00:00 -0400

July 5, 2010 - Quintiles announces a strategic alliance agreement with the University Malaya Medical Centre (UMMC) as part of its unique Prime Site program.

Malaysia Prime Site

Fri, 02 Jul 2010 14:32:25 -0400

Adam Chasse, Sr. Director, Access to Patients explains the importance of Prime Sites and the impact of our clinical research partnership with the University of Malaya Medical Centre in Malaysia.

Strategic Response

Thu, 24 Jun 2010 15:55:50 -0400

Quintiles was selected for geographical presence, previous experience in oncology, and a study team of professionals who had recently completed a trial on lung cancer. Download the PDF

Responsive Recruitment

Thu, 24 Jun 2010 15:49:35 -0400

Quintiles demonstrated the ability to quickly adapt to changing circumstances and to scale appropriate resources at short notice in order to meet shifting needs. Download the PDF

Targeting Oncology

Wed, 02 Jun 2010 15:36:02 -0400

Learn more about Quintiles leadership in oncology product development and commercialization. Download the PDF

Applications of Modeling and Simulation in Cardiac Safety Studies

Thu, 27 May 2010 15:35:28 -0400

Applications of Modeling and Simulation is discussed by Giridhar S. Tirucherai PhD, Director, Clinical PK-PD at Quintiles in the April issue of DIA Global Forum.

Eric Siemers, MD

Thu, 20 May 2010 09:25:02 -0400

Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT

Tue, 18 May 2010 00:00:00 -0400

May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program

Regulatory Landscapes for Future Antidiabetic Drug Development

Wed, 12 May 2010 15:36:59 -0400

In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk. Download the PDF

EMA’s Guidance on New Antidiabetic Drug Development

Wed, 12 May 2010 14:33:05 -0400

Assessing the EMA’s Guidance on New Antidiabetic Drug Development In January 2010, the European Medicines Agency (EMA) issued a draft guideline on antidiabetic drug development

Navigating Future Challenges in Alzheimer's Disease Trials

Mon, 10 May 2010 13:04:28 -0400

Learn more about this exciting program

Emerging Biopharma Service Fact Sheet

Tue, 04 May 2010 00:25:54 -0400

Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies. Download the PDF

FDA Requirements for Clinical Studies in Pediatric Patients

Thu, 01 Apr 2010 15:26:38 -0400

FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy Download the PDF

Propelling Pediatric Research

Thu, 01 Apr 2010 15:05:24 -0400

Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study Download the PDF

Boosting Pediatric Enrollment

Thu, 01 Apr 2010 14:54:03 -0400

Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. Download the PDF

Mapping the Future in Oncology Drug Development

Mon, 29 Mar 2010 12:21:45 -0400

A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development. Download the PDF

Integration of Molecular Biomarkers into Clinical Development

Mon, 29 Mar 2010 11:14:02 -0400

Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. Download the PDF

Regulations for Clinical Studies in Pediatric Patients in the European Union

Wed, 10 Mar 2010 14:36:34 -0400

After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric Download the PDF

Anticipating the Challenge

Wed, 03 Mar 2010 21:47:14 -0400

Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study. Download the PDF

Advancing Innovation

Wed, 03 Mar 2010 21:47:14 -0400

Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales. Download the PDF

Alzheimer's Inroads

Wed, 03 Mar 2010 21:34:48 -0400

A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site. Download the PDF

Trumping Expectations

Mon, 01 Mar 2010 14:40:30 -0400

Quintiles sails past recruitment hurdles with tailored approaches that build momentum Download the PDF

PharmAsia News Article Reprint

Mon, 01 Mar 2010 09:21:33 -0400

Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News. Download the PDF

Multinational Coordination

Fri, 26 Feb 2010 14:51:08 -0400

Coordinating a non-Hodgkin’s lymphoma study across six countries, our expert team exceeded expectations for efficiency and communication. Download the PDF

Key Trends in Multiple Myeloma Treatment

Fri, 26 Feb 2010 11:30:43 -0400

An overview of the latest studies into novel drug combinations and new therapies in early stage testing in multiple myeloma. Download the PDF

Biomarker Trends in Breast Cancer Research

Wed, 24 Feb 2010 16:30:43 -0400

Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. Download the PDF

Journal for Clinical Studies

Fri, 19 Feb 2010 11:00:10 -0400

In the January 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the FDA Guidance on diabetes drugs and cardiovascular risk. Download the PDF

QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY

Wed, 17 Feb 2010 11:12:46 -0400

February 17, 2010 - Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.

Global Efficiency

Wed, 10 Feb 2010 12:00:00 -0400

Read how Quintiles handled an eight-week hiatus due to a major protocol change and still trimmed two months off the enrollment period. Download the PDF

Swift Specialized Recruitment

Wed, 10 Feb 2010 12:00:00 -0400

Experience in the gastroenterology therapeutic area and the implementation of a multimedia recruitment campaign enabled Quintiles to complete enrollment five months ahead of schedule. Download the PDF

BIOS Standardize Data with SPARC

Tue, 02 Feb 2010 00:00:00 -0400

There is an increasing global requirement for Clinical Data Interchange Standards Consortium (CDISC) -based standardized data for regulatory submissions. At Quintiles, we have proactively addressed this need by training our staff, gaining experience, and developing and implementing innovative solutions for creating data that adhere to current CDISC Study Data Tabulation Model (SDTM) specifications. Download the PDF

New FDA Guidance on Antidiabetic Therapies

Fri, 11 Dec 2009 06:00:00 -0400

Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

Chasing Influenza

Mon, 30 Nov 2009 06:00:00 -0400

The rise in influenza strains like H1N1 — and the demand for new vaccines — signals a new era in vaccines. Learn how flu vaccines have evolved and where they’re headed. Download the PDF

Early Phase Optimization Strategies

Wed, 18 Nov 2009 14:15:08 -0400

As payers balk at rising drug prices and patent expirations threaten the industry’s revenue streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with drug development and, simultaneously, speed the process up. Download the PDF

Centralized Data Access for Total Study Control

Wed, 18 Nov 2009 13:53:11 -0400

Quintiles’ Interactive Response Technology (IRT) platform SEAMLESSLY integrates patient interaction systems for clinical development with the supply chain services of clinical labeling, packaging and distribution. Download the PDF

Hepatitis B Vaccine-Successful Study Strategy in Asia

Mon, 09 Nov 2009 16:48:01 -0400

Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. Download the PDF

Coordinating Safety Across Functions and Phases

Tue, 03 Nov 2009 17:43:07 -0400

Facing significant challenges with clinical and post-marketing safety, a customer needed an ally who could provide a full range of safety and risk management solutions. Download the PDF

Enabling Transformation

Wed, 30 Sep 2009 13:22:07 -0400

Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. Download the PDF

QUINTILES INCREASES CAPACITY TO SUPPORT EUROPEAN CLINICAL TRIALS

Thu, 24 Sep 2009 11:39:33 -0400

September 24, 2009 - Quintiles Transnational Corp. announced the opening of an expanded regional facility near Edinburgh, Scotland; space for Quintiles Clinical Development Services, including Project Management, Regulatory Affairs and Data Management.

Nasal Influenza Vaccine

Tue, 22 Sep 2009 09:39:24 -0400

Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. Download the PDF

Podcast: Changing the Face of Cancer Research

Mon, 31 Aug 2009 12:13:18 -0400

Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. Download the PDF

Podcast: Changing the Face of Cancer Research

Mon, 31 Aug 2009 12:13:18 -0400

Testing Disaster Readiness for Our Customer's Protection

Mon, 10 Aug 2009 12:57:42 -0400

Learn how Quintiles' planning protects trial data and provides seamless business continuity for clinical trials. Download the PDF

Sub-Saharan Africa Phase II/III Fact Sheet

Wed, 29 Jul 2009 11:37:27 -0400

Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. Download the PDF

Validated Biomarker Menu

Tue, 14 Jul 2009 11:00:55 -0400

A comprehensive menu of validated cell, fluid and tissue based biomarker assays. Download the PDF

eCTD Submissions

Sun, 21 Jun 2009 16:41:09 -0400

Read this case study which details information on eCTD submissions. Download the PDF

Regulatory and Medical Writing Serivces

Sun, 21 Jun 2009 16:24:19 -0400

Brochure featuring information on Regulatory and Medical Writing Services. Download the PDF

China Phase II/III Fact Sheet

Sun, 21 Jun 2009 15:48:22 -0400

Enormous potential for your trials — Quintiles’ operational expertise combined with rapid access to patients. Download the PDF

Whole World in Your Hands

Wed, 17 Jun 2009 10:27:16 -0400

Our Locations in 54 Countries Aren’t Just Dots on a Map –They’re Links in a True Global Network. Download the PDF

With so many CROs out there, which one is the best?

Fri, 05 Jun 2009 10:35:56 -0400

PharmaceuticalJobSite.com decided "to try and determine which is the best CRO....we have decided on which CRO we feel has the best overall reputation."

Advanced Gastric Cancer

Tue, 12 May 2009 14:27:45 -0400

To meet the challenges in patient recruitment, Quintiles relied on its therapeutic experience and extensive global site network to select the study sites most likely to treat patients meeting study entry criteria. In order to assist oncologists in working with the primary-tumor-related inclusion criteria, CRAs provided training to all sites based on a radiological briefing document. Download the PDF

QUINTILES NAMED BEST CLINICAL SERVICE PROVIDER

Thu, 23 Apr 2009 11:12:39 -0400

April 23, 2009 - Quintiles was named by industry decision-makers as the most favored contract research organization (CRO), according to two recently released independent surveys.

Badania Kliniczne

Fri, 10 Apr 2009 10:11:23 -0400

Quintiles Poland świadczy usługi związane z organizacją i monitorowaniem Badań Klinicznych faz I-IV. Każdy nowy lek - zanim będzie dostępny w sprzedaży- musi przejść fazę wszechstronnych, specjalistycznych testów i uzyskać aprobatę organów rejestracyjnych.

Contracting Timeline

Fri, 27 Mar 2009 16:44:36 -0400

Aggressive Recruitment Speeds Time to Market. The goal: to accelerate a study of a top-priority drug for non-myeloid malignancy. Quintiles ramped up 36 sites in just two months. Download the PDF

Supercharging Possibilities

Fri, 27 Mar 2009 16:42:45 -0400

Recruiting the Right Breast Cancer Patients. Finding HER2 positive metastatic breast cancer patients, Quintiles doubled the sponsor’s enrollment rate in less than a year. Download the PDF

Monitoring for Quality

Thu, 22 May 2008 11:14:34 -0400

Scott Cooley, Executive Director, Phase IIIb/IV Product Management, Quintiles, discusses innovative and traditional resources in a risk-based monitoring program. Download the PDF